M&G Investments is part of M&G plc, an international savings and investment business with millions of customers globally.
Portfolio
2
companies
AUM
£344000M
under management
Envisics
Envisics develops dynamic holographic technology for automotive augmented reality displays.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops DNA and RNA sequencing systems for scientific research and public health.
Jack Daniels
Chief Investment Officer
Jack brings investment management experience from roles at M&G Investments, alongside chair and advisory positions across the wealth and asset management sector.
The funding round was backed by M&G Investments and Van Tuyl Companies to accelerate product development and international expansion.
"To have such a strong close to our Series C strategic funding round is a testament to the momentum built by Dr. Christmas and the team at Envisics. We were an early investor in Envisics, and we welcome the very impressive roster of returning and new investors in this round."
M&G Investments contributed £35m to the £195m private transaction alongside Temasek, Wellington Management, and Nikon.
"The technology developed by Oxford Nanopore is being used in a broad range of scientific research applications, including to further biomedical science, to characterise pathogens in microbiology and public health. This is an example of how institutional investors can play an important role in accelerating growth in companies that provide a wider benefit to society."